Literature DB >> 19224311

SPG11 spastic paraplegia. A new cause of juvenile parkinsonism.

Mathieu Anheim1, Clotilde Lagier-Tourenne, Giovanni Stevanin, Marie Fleury, Alexandra Durr, Izzie Jacques Namer, Paola Denora, Alexis Brice, Jean-Louis Mandel, Michel Koenig, Christine Tranchant.   

Abstract

Autosomal recessive hereditary spastic paraplegia (AR HSP) with thin corpus callosum (TCC) is a rare neurodegenerative disorder often caused by mutations in the gene encoding for spatacsin at the SPG11 locus on chromosome 15q. The disease is characterized by progressive spastic paraparesis and mental retardation which occur during the first two decades of life and frequently with peripheral neuropathy. Brain magnetic resonance imaging (MRI) reveals typical TCC with periventricular white matter changes. We describe two patients, of Turkish descent, from the same consanguineous family and affected with SPG11 in association with unusual early-onset parkinsonism. Parkinsonism occurred during the very early stages of SPG11 in both patients, being in one the inaugural symptom of the disease presented as a resting tremor with akinesia, rigidity and expressing an initial moderate levodopa-response that progressively weakened. The second patient presented a resting tremor with mild akinesia and no levodopa-response. Both patients were affected with progressive spastic paraparesis which had initially occurred at 15 and 12 years of age, respectively, in association with mild mental retardation and an axonal polyneuropathy. TCC with periventricular white matter changes (PWMC) was evident by MRI and (123)I-ioflupane SPECT was abnormal. Genetic analysis detected for both patients a new c.704_705delAT, p.H235RfsX12 homozygous mutation in SPG11. This report provides evidence that parkinsonism may initiate SPG11-linked HSP TCC and that SPG11 may cause juvenile parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224311     DOI: 10.1007/s00415-009-0083-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Two novel mutations in the SPG11 gene causing hereditary spastic paraplegia associated with thin corpus callosum.

Authors:  Shu-Shan Zhang; Qin Chen; Xue-Ping Chen; Jian-Gang Wang; Jean-Marc Burgunder; Hui-Fang Shang; Jean-Marc Burgunder; Yuan Yang
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

2.  Neurological and neuroradiological progression in hereditary spastic paraplegia with a thin corpus callosum.

Authors:  S Okubo; M Ueda; T Kamiya; S Mizumura; A Terashi; Y Katayama
Journal:  Acta Neurol Scand       Date:  2000-09       Impact factor: 3.209

3.  Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity.

Authors:  Giovanni Stevanin; Giorgia Montagna; Hamid Azzedine; Enza Maria Valente; Alexandra Durr; Valentina Scarano; Naima Bouslam; Denise Cassandrini; Paola S Denora; Chiara Criscuolo; Soraya Belarbi; Antonio Orlacchio; Philippe Jonveaux; Gabriella Silvestri; Anne Marie Ouvrad Hernandez; Giuseppe De Michele; Meriem Tazir; Caterina Mariotti; Knut Brockmann; Alessandro Malandrini; Marjo S van der Knapp; Marcella Neri; Hassan Tonekaboni; Mariarosa A B Melone; Alessandra Tessa; M Teresa Dotti; Michela Tosetti; Flavia Pauri; Antonio Federico; Carlo Casali; Vitor T Cruz; José L Loureiro; Federico Zara; Sylvie Forlani; Enrico Bertini; Paula Coutinho; Alessandro Filla; Alexis Brice; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2006-05-13       Impact factor: 2.660

4.  Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration.

Authors:  Giovanni Stevanin; Hamid Azzedine; Paola Denora; Amir Boukhris; Meriem Tazir; Alexander Lossos; Alberto Luis Rosa; Israela Lerer; Abdelmadjid Hamri; Paulo Alegria; José Loureiro; Masayoshi Tada; Didier Hannequin; Mathieu Anheim; Cyril Goizet; Victoria Gonzalez-Martinez; Isabelle Le Ber; Sylvie Forlani; Kiyoshi Iwabuchi; Vardiela Meiner; Goekhan Uyanik; Anne Kjersti Erichsen; Imed Feki; Florence Pasquier; Soreya Belarbi; Vitor T Cruz; Christel Depienne; Jeremy Truchetto; Guillaume Garrigues; Chantal Tallaksen; Christine Tranchant; Masatoyo Nishizawa; José Vale; Paula Coutinho; Filippo M Santorelli; Chokri Mhiri; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2007-12-13       Impact factor: 13.501

5.  Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia.

Authors:  Ute Hehr; Peter Bauer; Beate Winner; Rebecca Schule; Akguen Olmez; Wolfgang Koehler; Goekhan Uyanik; Anna Engel; Daniela Lenz; Andrea Seibel; Andreas Hehr; Sonja Ploetz; Josep Gamez; Arndt Rolfs; Joachim Weis; Thomas M Ringer; Michael Bonin; Gerhard Schuierer; Joerg Marienhagen; Ulrich Bogdahn; Bernhard H F Weber; Haluk Topaloglu; Ludger Schols; Olaf Riess; Juergen Winkler
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

6.  Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity.

Authors:  Amir Boukhris; Giovanni Stevanin; Imed Feki; Elodie Denis; Nizar Elleuch; Mohamed Imed Miladi; Jérémy Truchetto; Paola Denora; Samir Belal; Chokri Mhiri; Alexis Brice
Journal:  Arch Neurol       Date:  2008-03

Review 7.  [Three patients of complicated form of autosomal recessive hereditary spastic paraplegia associated with hypoplasia of the corpus callosum].

Authors:  K Iwabuchi; Y Kubota; T Hanihara; H Nagatomo
Journal:  No To Shinkei       Date:  1994-10

8.  The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum.

Authors:  Heidi C Howard; David B Mount; Daniel Rochefort; Nellie Byun; Nicolas Dupré; Jianming Lu; Xuemo Fan; Luyan Song; Jean-Baptiste Rivière; Claude Prévost; Jürgen Horst; Alessandro Simonati; Beate Lemcke; Rick Welch; Roger England; Frank Q Zhan; Adriana Mercado; William B Siesser; Alfred L George; Michael P McDonald; Jean-Pierre Bouchard; Jean Mathieu; Eric Delpire; Guy A Rouleau
Journal:  Nat Genet       Date:  2002-10-07       Impact factor: 38.330

9.  Familial spastic paraplegia with mental impairment and thin corpus callosum.

Authors:  A Nakamura; K Izumi; F Umehara; M Kuriyama; Y Hokezu; M Nakagawa; K Shimmyozu; S Izumo; M Osame
Journal:  J Neurol Sci       Date:  1995-07       Impact factor: 3.181

10.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum.

Authors:  Giovanni Stevanin; Filippo M Santorelli; Hamid Azzedine; Paula Coutinho; Jacques Chomilier; Paola S Denora; Elodie Martin; Anne-Marie Ouvrard-Hernandez; Alessandra Tessa; Naïma Bouslam; Alexander Lossos; Perrine Charles; José L Loureiro; Nizar Elleuch; Christian Confavreux; Vítor T Cruz; Merle Ruberg; Eric Leguern; Djamel Grid; Meriem Tazir; Bertrand Fontaine; Alessandro Filla; Enrico Bertini; Alexandra Durr; Alexis Brice
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

View more
  29 in total

1.  Expanding the clinical spectrum of SPG11 gene mutations in recessive hereditary spastic paraplegia with thin corpus callosum.

Authors:  Alice Abdel Aleem; Nourhan Abu-Shahba; Dominika Swistun; Jennifer Silhavy; Stephanie L Bielas; Shifteh Sattar; Joseph G Gleeson; Maha S Zaki
Journal:  Eur J Med Genet       Date:  2010-11-12       Impact factor: 2.708

2.  SPG15: a cause of juvenile atypical levodopa responsive parkinsonism.

Authors:  Martial Mallaret; Ouhaid Lagha-Boukbiza; Saskia Biskup; Izzie Jacques Namer; Gabrielle Rudolf; Mathieu Anheim; Christine Tranchant
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

3.  Neurotransmitter abnormalities and response to supplementation in SPG11.

Authors:  Adeline Vanderver; Davide Tonduti; Sarah Auerbach; Johanna L Schmidt; Sumit Parikh; Gordon C Gowans; Kelly E Jackson; Pamela L Brock; Marc Patterson; Michelle Nehrebecky; Rena Godfrey; Wadih M Zein; William Gahl; Camilo Toro
Journal:  Mol Genet Metab       Date:  2012-06-01       Impact factor: 4.797

4.  Is Pallido-Pyramidal Syndrome Still a Useful Concept? Yes.

Authors:  Christine Tranchant
Journal:  Mov Disord Clin Pract       Date:  2019-10-14

5.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).

Authors:  Alejandro Estrada-Cuzcano; Shaun Martin; Teodora Chamova; Matthis Synofzik; Dagmar Timmann; Tine Holemans; Albena Andreeva; Jennifer Reichbauer; Riet De Rycke; Dae-In Chang; Sarah van Veen; Jean Samuel; Ludger Schöls; Thorsten Pöppel; Danny Mollerup Sørensen; Bob Asselbergh; Christine Klein; Stephan Zuchner; Albena Jordanova; Peter Vangheluwe; Ivailo Tournev; Rebecca Schüle
Journal:  Brain       Date:  2017-02       Impact factor: 13.501

Review 6.  Parkinsonism and inborn errors of metabolism.

Authors:  A Garcia-Cazorla; S T Duarte
Journal:  J Inherit Metab Dis       Date:  2014-06-07       Impact factor: 4.982

Review 7.  Rare causes of dystonia parkinsonism.

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

8.  Rapidly deteriorating course in Dutch hereditary spastic paraplegia type 11 patients.

Authors:  Susanne T de Bot; Rogier C Burggraaff; Johanna C Herkert; Helenius J Schelhaas; Bart Post; Adinda Diekstra; Reinout O van Vliet; Marjo S van der Knaap; Erik-Jan Kamsteeg; Hans Scheffer; Bart P van de Warrenburg; Corien C Verschuuren-Bemelmans; Hubertus P H Kremer
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 9.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

10.  Autosomal recessive hereditary spastic paraplegia-clinical and genetic characteristics of a well-defined cohort.

Authors:  G Yoon; B Baskin; M Tarnopolsky; K M Boycott; M T Geraghty; E Sell; S Goobie; W Meschino; B Banwell; P N Ray
Journal:  Neurogenetics       Date:  2013-06-04       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.